title: Endoscopic biopsy on patients taking antiplatelet agents: how much do we follow BSG, ASGE or ESGE guidelines?
authors.affiliation: Department of Surgery, Ealing NHS Trust, London, W7 3QA, UK, draswini@gmail.com.
authors.forename: Aswini K
authors.initials: AK
authors.lastname: Misro
authors.forename: Hemant
authors.initials: H
authors.lastname: Sheth
authors.forename: Arabinda
authors.initials: A
authors.lastname: Pal
mesh_terms: D001241:Aspirin / Q000009:adverse effects; D001706:Biopsy / Q000009:adverse effects / Q000706:statistics & numerical data*; D000077144:Clopidogrel; D016099:Endoscopy, Gastrointestinal / Q000009:adverse effects / Q000706:statistics & numerical data*; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D010820:Physicians / Q000706:statistics & numerical data*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D011364:Professional Practice / Q000706:statistics & numerical data*; D012306:Risk; D011795:Surveys and Questionnaires; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin